Scrambler Therapy no Controle da Dor Oncológica Crônica: Revisão Integrativa da Literatura
DOI:
https://doi.org/10.32635/2176-9745.RBC.2022v68n1.1656Palavras-chave:
neoplasias, estimulação elétrica nervosa transcutânea, manejo da dor, dor do câncer/terapia, dor crônicaResumo
Introdução: A Scrambler therapy é uma nova e não invasiva modalidade de eletroanalgesia com a intenção de organizar a má adaptação dos sinais elétricos de nervos periféricos. Objetivo: Avaliar o benefício clínico da Scrambler therapy no controle de intensidade da dor em pacientes oncológicos. Método: Revisão da literatura conforme a metodologia Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) nas bases de dados eletrônicas LILACS, PEDro, SciELO e PubMed. Foram combinados aleatoriamente os descritores: “Scrambler therapy”, “cancer”, “pain”, assim como o uso dos operadores booleanos AND e OR, em português, inglês e espanhol, sem limite de tempo. Resultados: Foram incluídos 15 estudos que, após avaliação crítica, demonstraram benefício clínico na redução na intensidade da dor. A Scrambler therapy é baseada em cinco neurônios artificiais controlados por um algoritmo otimizado para fornecer segurança e eficácia. O hardware recebe informações do algoritmo que cria as sequências de caracteres “não-dor” e as processa, transformando-as em fluxos potenciais de ação sintéticos (isto é, criados pela tecnologia) funcionalmente compatíveis com os potenciais endógenos. Conclusão: Os resultados positivos encontrados nos estudos preliminares com a Scrambler therapy indicam benefícios no controle da dor oncológica.
Downloads
Referências
Neufeld NJ, Elnahal SM, Alvarez RH. Cancer pain: a review of epidemiology, clinical quality and value impact. Future Oncol. 2017;13(9):833-41. doi: https://doi.org/10.2217/fon-2016-0423 DOI: https://doi.org/10.2217/fon-2016-0423
Marineo G. Inside the Scrambler therapy, a noninvasive treatment of chronic neuropathic and cancer pain: from the gate control theory to the active principle of information. Integr Cancer Ther. 2019;18:1534735419845143. doi: https://doi.org/10.1177/1534735419845143 DOI: https://doi.org/10.1177/1534735419845143
Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003;4(1):1-10. Cited in: PubMed; PMID: 12555009.
Sabato AF, Marineo G, Gatti A. Scrambler therapy. Minerva Anestesiol. 2005;71(7-8):479-82. Cited in: PubMed; PMID: 16012423.
Lee JS. Efficacy of Scrambler therapy on breast cancer-related lymphedema. J Phys Ther Sci. 2018;30(11):1370-1. doi: https://doi.org/10.1589/jpts.30.1370 DOI: https://doi.org/10.1589/jpts.30.1370
Smith T, Cheville AL, Loprinzi CL, et al. Scrambler therapy for the treatment of chronic post-mastectomy pain (cPMP). Cureus. 2017;9(6):e1378. doi: https://doi.org/10.7759/cureus.1378 DOI: https://doi.org/10.7759/cureus.1378
Tomasello C, Pinto RM, Mennini C, et al. Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: a preliminary study. Pediatr Blood Cancer. 2018;65(7):e27064. doi: https://doi.org/10.1002/pbc.27064 DOI: https://doi.org/10.1002/pbc.27064
Notaro P, Dell'Agnola CA, Dell'Agnola AJ, et al. Pilot evaluation of Scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies. Support Care Cancer. 2016;24(4):1649-54. doi: https://doi.org/10.1007/s00520-015-2952-x DOI: https://doi.org/10.1007/s00520-015-2952-x
Pachman DR, Weisbrod BL, Seisler DK, et al. Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2015;23(4):943-51. doi: https://doi.org/10.1007/s00520-014-2424-8 DOI: https://doi.org/10.1007/s00520-014-2424-8
Kashyap K, Joshi S, Vig S, et al. Impact of Scrambler therapy on pain management and quality of life in cancer patients: a study of twenty cases. Indian J Palliat Care. 2017;23(1):18-23. doi: https://doi.org/10.4103/0973-1075.197948 DOI: https://doi.org/10.4103/0973-1075.197948
Loprinzi C, Le-Rademacher JG, Majithia N, et al. Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial. Support Care Cancer. 2020;28(3):1183-97. doi: https://doi.org/10.1007/s00520-019-04881-3 DOI: https://doi.org/10.1007/s00520-019-04881-3
Park HS, Kim WJ, Kim HG, et al. Scrambler therapy for the treatment of neuropathic pain related to leukemia in a pediatric patient: a case report. Medicine (Baltimore). 2017;96(45):e8629. doi: https://doi.org/10.1097/MD.0000000000008629 DOI: https://doi.org/10.1097/MD.0000000000008629
Lee SC, Park KS, Moon JY, et al. An exploratory study on the effectiveness of "Calmare therapy" in patients with cancer-related neuropathic pain: a pilot study. Eur J Oncol Nurs. 2016;21:1-7. doi: https://doi.org/10.1016/j.ejon.2015.12.001 DOI: https://doi.org/10.1016/j.ejon.2015.12.001
Coyne PJ, Wan W, Dodson P, et al. A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. 2013;27(4):359-64. doi: https://doi.org/10.3109/15360288.2013.847519 DOI: https://doi.org/10.3109/15360288.2013.847519
Ricci M, Fabbri L, Pirotti S, et al. Scrambler therapy: what's new after 15 years? The results from 219 patients treated for chronic pain. Medicine (Baltimore). 2019;98(2):e13895. doi: https://doi.org/10.1097/MD.0000000000013895 DOI: https://doi.org/10.1097/MD.0000000000013895
Kashyap K, Singh V, Mishra S, et al. The efficacy of Scrambler therapy for the management of head, neck and thoracic cancer pain: a randomized controlled trial. Pain Physician. 2020;23(5):495-506. Cited in: PubMed; PMID: 32967392. DOI: https://doi.org/10.36076/ppj.2020/23/495
Smith TJ, Coyne PJ, Parker GL, et al. Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2010;40(6):883-91. doi: https://doi.org/10.1016/j.jpainsymman.2010.03.022 DOI: https://doi.org/10.1016/j.jpainsymman.2010.03.022
Childs DS, Le-Rademacher JG, McMurray R, et al. Randomized trial of Scrambler therapy for chemotherapy-induced peripheral neuropathy: crossover analysis. J Pain Symptom Manage. 2021;61(6):1247-53. doi: https://doi.org/10.1016/j.jpainsymman.2020.11.025 DOI: https://doi.org/10.1016/j.jpainsymman.2020.11.025
Majithia N, Smith TJ, Coyne PJ, et al. Scrambler therapy for the management of chronic pain. Support Care Cancer. 2016;24(6):2807-14. doi: https://doi.org/10.1007/s00520-016-3177-3 DOI: https://doi.org/10.1007/s00520-016-3177-3
Starkweather AR, Coyne P, Lyon DE, et al. Decreased low back pain intensity and differential gene expression following calmare®: results from a double-blinded randomized sham-controlled study. Res Nurs Health. 2015;38(1):29-38. doi: https://doi.org/10.1002/nur.21632 DOI: https://doi.org/10.1002/nur.21632
Ghatak RK, Nandi SN, Bhakta A, et al. Prospective study of application of biological communication (cybernatics) in management of chronic low back pain--a preliminary report. Nepal Med Coll J. 2011;13(4):257-60. Cited in: PubMed; PMID: 23016475.
Smith TJ, Marineo G. Treatment of postherpetic pain with Scrambler therapy, a patient-specific neurocutaneous electrical stimulation device. Am J Hosp Palliat Care. 2018;35(5):812-3. doi: https://doi.org/10.1177/1049909113494002 DOI: https://doi.org/10.1177/1049909113494002
Moon JY, Kurihara C, Beckles JP, et al. Predictive factors associated with success and failure for calmare (Scrambler) therapy: a multicenter analysis. Clin J Pain. 2014;31:750-56. doi: https://doi.org/10.1097/AJP.0000000000000155 DOI: https://doi.org/10.1097/AJP.0000000000000155
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
